Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression-Reference-Cited by-同舟云学术

Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression

Published:2013-08-01 Issue:8 Volume:8 Page:e70019
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gnanapavan Sharmilee,Grant Donna,Morant Steve,Furby Julian,Hayton Tom,Teunissen Charlotte E.,Leoni Valerio,Marta Monica,Brenner Robert,Palace Jacqueline,Miller David H.,Kapoor Raj,Giovannoni Gavin

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference22 articles.

1. Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study;A Petzold;J Neurol Neurosurg Psychiatry,2005

2. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury;G Shaw;Biochem Biophys Res Commun,2005

3. Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis;J Kuhle;Neurology,2011

4. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis;CE Teunissen;Neurology,2009

5. Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis;A Petzold;Mult Scler,2004

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium channel inhibitors alter the progress of tangle development in a mouse model of dementia;2024-08-27

2. Temporal Profile of Serum Neurofilament Light (NF-L) and Heavy (pNF-H) Level Associations With 6-Month Cognitive Performance in Patients With Moderate-Severe Traumatic Brain Injury;Journal of Head Trauma Rehabilitation;2024-05-14

3. Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review;Frontiers in Molecular Neuroscience;2023-09-12

4. Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels;Pharmaceuticals;2023-07-07

5. Molecular biomarkers and cognitive impairment in multiple sclerosis: State of the field, limitations, and future direction – A systematic review and meta-analysis;Neuroscience & Biobehavioral Reviews;2023-03